Crossmark

Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy

Crossref DOI link: https://doi.org/10.1016/j.redox.2016.10.010

Published Print: 2016-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Doskey, Claire M.

Buranasudja, Visarut

Wagner, Brett A.

Wilkes, Justin G.

Du, Juan

Cullen, Joseph J.

Buettner, Garry R.
Funding

Funding for this research was provided by:

National Institutes of Health (R01 CA169046)

National Institutes of Health (R01 GM073929)

National Institutes of Health (T32 CA148062)

National Institutes of Health (P42 ES013661)

National Institutes of Health (P30 ES005605)

National Institutes of Health (R01 CA184051)

The Gateway for Cancer Research

Holden Comprehensive Cancer Center (P30 CA086862)
License Information

Text and Data Mining valid from 2016-12-01

Text and Data Mining valid from 2016-12-01

Version of Record valid from 2016-10-18
More Information

This article is maintained by: Elsevier

Article Title: Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy

Journal Title: Redox Biology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.redox.2016.10.010

Content Type: article

Copyright: © 2016 The Authors. Published by Elsevier B.V.